Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sherwood Scientific Exhibits Solution for Enzyme-Based Diagnostic Testing in Remote Locations

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013.

The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific’s magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.

The Model 260uv Programmable Colorimeter’s ability to operate in the near UV region makes it ideal for enzyme-based clinical diagnostic tests. Until recently, it has been difficult to run these tests on cost-efficient instruments while in the field. The 260uv Colorimeter is rugged and portable, and can run using a variety of power sources, including a 12V car battery, making it a prime solution for use in field hospitals and remote locations. In addition, the system can store up to 100 methods, allowing the use of most commercially available test kits and user-generated reagents, further increasing the convenience of the whole system.

Sherwood Scientific will also showcase its unique benchtop magnetic susceptibility balance at MEDICA. This well-established product is suited for use when analysing iron-coated contrast agents, such as those used in magnetic resonance imaging, and ensuring their compliance in line with pharmacopoeia monographs. Visitors to the stand will also have the opportunity to explore the use of the model 926S Chloride Analyser, highly regarded in the diagnosis of cystic fibrosis for more than 15 years.

“We are very much looking forward to attending MEDICA 2013,” said Jon Copsey, Marketing Manager at Sherwood Scientific Ltd. “This will be Sherwood Scientific’s first time exhibiting at the show, and we are excited to demonstrate how our systems can benefit users in clinical areas. We know that working in this sector can produce some unique challenges, and are confident that visitors to the stand will come away with valuable solutions.”

Visitors to MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany) can find Sherwood Scientific at Hall 01/E07.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!